Last year at the Pharma Compliance Europe 2014 event, Karolina Czernicka-Kuhl, Novo Nordisk, Head of Legal and Compliand Europe East, gave the presentation "Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates."
Karolina Czernicka-Kuhl outlines in her presentation:
-
Why monitoring?
-
What should be monitored?
-
How to monitor (who should monitor)?
-
Benefits and costs